Novartis AG (NOVN) Stock Statistics & Valuation Metrics

Novartis AG has a market cap or net worth of CHF189.35B. The enterprise value is CHF208.96B.

Novartis AG has 2,112,421,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis AG’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.55%.

The current PE Ratio of Novartis AG is 16.6. Novartis AG’s PEG ratio is ―.

In the last 12 months, Novartis AG had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.92.

In the last 12 months, operating cash flow was 20.79B and capital expenditures -2.74B, giving a free cash flow of 18.05B billion.

Novartis AG pays an annual dividend of CHF3.5, resulting in a dividend yield of 3.49%

Novartis AG upcoming earnings date is Oct 28, 2025, TBA (Confirmed).

Novartis AG as a current ratio of 1.04, with Debt / Equity ratio of 77.73%

In the past 12 months, Novartis AG has paid 1.70B in taxes.

Novartis AG EV to EBITDA ratio is 10.47, with an EV/FCF ratio of 15.71.

Novartis AG has CHF7.00B in cash and marketable securities with CHF32.64B in debt, giving a net cash position of CHF25.64B billion.

Gross margin is 76.25%, with operating margin of 28.12%, and net profit margin of 23.09%.

The average price target for Novartis AG is CHF101.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy